UNICA IRIS Institutional Research Information System

LAI, ELEONORA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 35.550
NA - Nord America 1.911
AS - Asia 978
SA - Sud America 192
AF - Africa 36
OC - Oceania 6
Totale 38.673
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 34.882
US - Stati Uniti d'America 1.828
SG - Singapore 371
CN - Cina 323
SE - Svezia 242
BR - Brasile 144
DE - Germania 85
GB - Regno Unito 82
VN - Vietnam 80
CA - Canada 55
FI - Finlandia 48
FR - Francia 46
IN - India 39
NL - Olanda 34
HK - Hong Kong 33
PL - Polonia 33
KR - Corea 27
AR - Argentina 19
ES - Italia 19
MX - Messico 18
AT - Austria 15
IE - Irlanda 13
IQ - Iraq 13
ZA - Sudafrica 13
CO - Colombia 12
IR - Iran 12
JP - Giappone 12
TR - Turchia 11
AE - Emirati Arabi Uniti 9
ID - Indonesia 8
IS - Islanda 8
MA - Marocco 8
PK - Pakistan 7
UA - Ucraina 7
UZ - Uzbekistan 7
AU - Australia 6
EC - Ecuador 6
JE - Jersey 6
TZ - Tanzania 6
BD - Bangladesh 5
CZ - Repubblica Ceca 4
SA - Arabia Saudita 4
VE - Venezuela 4
AZ - Azerbaigian 3
BE - Belgio 3
LT - Lituania 3
PT - Portogallo 3
PY - Paraguay 3
RU - Federazione Russa 3
AL - Albania 2
BB - Barbados 2
DK - Danimarca 2
DZ - Algeria 2
EG - Egitto 2
IL - Israele 2
JM - Giamaica 2
LU - Lussemburgo 2
NO - Norvegia 2
PH - Filippine 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CR - Costa Rica 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GH - Ghana 1
GY - Guiana 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NG - Nigeria 1
NP - Nepal 1
RO - Romania 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 38.673
Salva come PNG Salva come JPEG
Città #
Cagliari 33.229
Uta 1.448
Ashburn 268
Singapore 196
Nyköping 164
Dallas 147
Chandler 144
Boardman 135
Fairfield 125
Beijing 95
Los Angeles 71
New York 66
Houston 55
Seattle 55
Wilmington 52
Woodbridge 47
Cambridge 39
Santa Clara 34
Boston 33
Hong Kong 32
Rome 32
Shanghai 32
San Diego 31
Helsinki 30
Munich 27
Hefei 24
Ho Chi Minh City 21
Redondo Beach 21
Toronto 19
Montreal 18
Seoul 18
Dong Ket 16
Frankfurt am Main 16
Chicago 15
Warsaw 15
London 14
Pune 14
Stockholm 14
São Paulo 14
Amsterdam 13
Nuremberg 13
Buffalo 12
Guangzhou 12
Hanoi 11
Rio de Janeiro 10
The Dalles 10
West Lafayette 10
Ann Arbor 9
Poznan 9
Tehran 9
Tokyo 9
Turku 9
Jacksonville 8
Reykjavik 8
Brooklyn 7
Casablanca 7
Denver 7
Lappeenranta 7
Mexico City 7
Milan 7
Tashkent 7
Bari 6
Chennai 6
Dar es Salaam 6
Dearborn 6
Düsseldorf 6
Miami 6
Málaga 6
Orem 6
Poplar 6
Portsmouth 6
Santiago de Cali 6
Selargius 6
Vienna 6
Andover 5
Baghdad 5
Casoria 5
Dubai 5
Durban 5
Johannesburg 5
Manchester 5
Menlo Park 5
Naaldwijk 5
Nanjing 5
Oxford 5
Roubaix 5
Salford 5
San Francisco 5
Wuhan 5
Atlanta 4
Calgary 4
Cleveland 4
Florence 4
Istanbul 4
Jersey 4
Kyjov 4
Lauterbourg 4
Naples 4
Norwalk 4
Phoenix 4
Totale 37.224
Salva come PNG Salva come JPEG
Nome #
BRAF-mutant colorectal cancer, a different breed evolving 3.211
Molecular-biology-driven treatment for metastatic colorectal cancer 2.716
HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples 2.639
Colorectal cancer early detection in stool samples tracing CPG islands methylation alterations affecting gene expression 2.325
From central to sentral (Serum angiogenesis central): Circulating predictive biomarkers to anti-VEGFR therapy 1.891
New therapeutic targets in pancreatic cancer 1.591
Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE-2 Study 1.584
Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients? 1.489
Molecular-driven treatment for biliary tract cancer: the promising turning point 1.183
The role of fetal programming in human carcinogenesis - May the Barker hypothesis explain interindividual variability in susceptibility to cancer insurgence and progression? 1.148
How to improve metastatic pancreatic ductal adenocarcinoma patients' selection: Between clinical trials and the real-world 1.136
null 1.080
The association between Major Depressive Disorder and premature death risk in hematologic and solid cancer: a longitudinal cohort study 986
Liquid Biopsy-Driven Cetuximab Rechallenge Strategy in Molecularly Selected Metastatic Colorectal Cancer Patients 903
Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? 899
Impact of Aspirin on clinical outcome in advanced HCC patients receiving sorafenib and regorafenib 864
The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment 814
Corrigendum: Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients 743
The Difficult Task of Diagnosing Depression in Elderly People with Cancer: A Systematic Review 714
Uncovering key targets of success for immunotherapy in pancreatic cancer 679
Lenvatinib versus Sorafenib as first-line treatment in hepatocellular carcinoma: A multi-institutional matched case-control study 658
Investigating the Ovarian Microstructure in the Genera Helicolenus and Scorpaena (Teleostei, Sub‐Order Scorpaenoidei) with Implications for Ovarian Dynamics and Spawning 654
Retrospective survival analysis in patients with metastatic pancreatic ductal adenocarcinoma with insulin-treated type 2 diabetes mellitus 623
Are All Anti-Angiogenic Drugs the Same in the Treatment of Second-Line Metastatic Colorectal Cancer? Expert Opinion on Clinical Practice 623
The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized trials 620
Identification of lenvatinib prognostic index via recursive partitioning analysis in advanced hepatocellular carcinoma 615
BRCA-mutant pancreatic ductal adenocarcinoma 583
Immune Checkpoint Inhibitors in the Treatment of HCC 551
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 543
EGFR-Mutated Non-Small Cell Lung Cancer and Resistance to Immunotherapy: Role of the Tumor Microenvironment 510
Long Term Survival With Regorafenib: REALITY (Real Life in Italy) Trial - A GISCAD Study 505
Prognostic Role of a New Index Tested in European and Korean Advanced Biliary Tract Cancer Patients: the PECS Index 500
Soft tissue epithelioid vascular tumors: a practical clinico pathological diagnostic approach 498
Correction to: Angiogenesis Genotyping and Clinical Outcomes in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib: The ALICE‑2 Study 470
Clinical outcomes of NSCLC patients experiencing early immune-related adverse events to PD-1/PD-L1 checkpoint inhibitors leading to treatment discontinuation 458
null 455
Understanding the user's point of view: when the doctor gets sick with cancer and seeks help 436
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma 204
A Novel Prognostic Tool in Western and Eastern Biliary Tract Cancer Patients Treated in First-line Setting: the ECSIPOT Index 202
Leptin as a surrogate immune-metabolic marker to predict impact of anti-cachectic therapy: results of a prospective randomized trial in multiple solid tumors 124
Association Between TP53 Mutations and Platinum Resistance in a Cohort of High-Grade Serous Ovarian Cancer Patients: Novel Implications for Personalized Therapeutics 98
Influence of levothyroxine concomitant treatment on treatment responses and outcomes in patients with metastatic colorectal adenocarcinoma 66
The interconnection between cellular metabolism and lymphocyte activation as a prognostic factor in patients affected by metastatic pancreatic ductal adenocarcinoma treated with gemcitabine and nab-paclitaxel as first line 58
Lymphocyte to monocyte ratio in metastatic pancreatic ductal adenocarcinoma as a prognostic factor and its potential role in identifying a subset of patients with a favorable response to therapy 55
Early onset metastatic colorectal cancer: Clinical-prognostic characteristics and correlation to molecular profile 54
Comparison between different therapeutic sequences in patients affected by metastatic pancreatic ductal adenocarcinoma 51
Totale 38.809
Salva come PNG Salva come JPEG
Categoria #
all - tutte 57.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 57.358
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.504 0 0 0 0 0 705 245 391 182 377 335 269
2021/20223.177 188 149 55 151 152 161 141 346 263 372 436 763
2022/20236.988 748 1.210 929 547 511 612 321 464 397 432 534 283
2023/20247.807 309 210 220 303 527 997 1.040 2.373 371 314 557 586
2024/202511.291 2.841 3.154 1.215 1.382 610 973 511 70 126 123 102 184
2025/20261.726 338 206 293 374 290 225 0 0 0 0 0 0
Totale 38.809